Lifecore Biomedical Inc expected to post a loss of 37 cents a share - Earnings Preview

Lifecore Biomedical

29/08/2023 13:33

* Lifecore Biomedical Inc  LFCR.OQ   LFCR.O  is expected
to show a
fall in quarterly revenue when it reports  results on August
31. 
    * The Chaska Minnesota-based  company is expected to report 
a
39.1% decrease in revenue to $29.024 million from $47.63 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lifecore Biomedical
Inc
is for a loss of 37 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $9.5​, above​ its last closing price of $8.38.
​​​

This summary was machine generated August 29 at 12:32 GMT.  All
figures in US dollars  unless otherwise stated